Skip to main content
. 2019 Jun 28;8(3):383–396. doi: 10.1007/s40121-019-0251-4

Table 3.

Median individual Bayesian posterior parameter estimates for the 11 tigecycline and 1 meropenem patient plus covariate-based parameter estimates for 1 tigecycline and 3 meropenem patients used to estimate pharmacodynamic exposure

Antibiotic/patient number Pharmacokinetic parameter estimatesa
CL (L/h) Vc (L) kcp (h−1) kpc (h−1)
Tigecycline
 3 22.3 118.9 5.688 1.883
 4 37.0 100.2 1.046 0.375
 5 19.0 89.1 1.945 1.269
 6 15.0 79.3 2.575 0.299
 7 37.0 100.3 1.045 0.376
 8 37.0 100.3 1.045 0.375
 9 22.5 149.0 3.583 1.986
 10 19.5 89.1 4.152 1.268
 11 24.2 26.1 7.885 0.110
 12 19.4 21.9 4.195 0.490
 16 19.2 88.6 3.540 1.262
 17b 17.1 N/A N/A N/A
Meropenem
 1c 10.2 16.7 0.487 0.647
 2c 9.5 16.5 0.487 0.647
 4 22.0 40.9 9.95 4.41
 15c 6.3 14.3 0.487 0.647

CL clearance, Vc volume of distribution of the central compartment, kcp and kpc intercompartment transfer constants between central and peripheral compartments and vice versa, respectively, fAUC/MIC free area under the curve to minimum inhibitory concentration ratio, fT > MIC free time above the minimum inhibitory concentration, N/A not available

aAll pharmacokinetic parameter estimates are derived from the Bayesian posterior model fits in Pmetrics, except for patients 1, 2, 15, and 17 (see footnotes)

bConcentration data not available for this patient. Exposure estimated using a covariate-based model [15], as 24-h maintenance dose divided by CL, where CL = [(9.6 + (10.2 × BSA − 1.73))] + [(0.0638 × (CrCL − 100)], where BSA is body surface area and CrCL is baseline creatinine clearance

cConcentration data not available for two patients (1 and 2), and observed versus predicted concentrations were poorly fit for patient 15. Exposure estimated using a covariate-based model [13], based on clearance [CL = (0.392 + 0.003 × CrCL)], volume of the central compartment [Vc = 0.239 ×  adjusted body weight, where adjusted body weight = IBW +  [0.4 × (ABW − IBW) or if adjusted body weight is < 20% above ideal body weight (IBW), then actual body weight used (ABW)], and median population estimates for kcp and kpc